Yanxia Zhao

Also affiliated with National Health and Family Planning Commission, National Center for Women and Children’s Health, China CDC, Wuhan Union Hospital, Union Hospital, Huazhong University of Science and Technology, Hubei University

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “COVID-19 in cancer patients: risk, clinical features, and management”.

COVID-19 in cancer patients: risk, clinical features, and management

Cancer Biology and Medicine(2020)10.20892/j.issn.2095-3941.2020.0289

N/A

0DataRank · unranked

237 citations

Yanxia Zhao, Derick Okwan‐Duodu, Reva Basho, Xiaojiang Cui, Cuiwei Liu

Breast cancer liver metastasis: Pathogenesis and clinical implications

Frontiers in Oncology(2022)10.3389/fonc.2022.1043771

N/A

0DataRank · unranked

27 citations

Srivarshini Cherukupalli Mohan, Jielin Wei, Ekihiro Seki, Manran Liu, Reva Basho +4 more

Losartan rewires the tumor-immune microenvironment and suppresses IGF-1 to overcome resistance to chemo-immunotherapy in ovarian cancer

British Journal of Cancer(2024)10.1038/s41416-024-02863-9

N/A

0DataRank · unranked

16 citations

Zhenzhen Yin, Shuang Li, Limeng Wu, Yanling Zhang, Yanxia Zhao +9 more